Apollo’s Apollo Connect program bets big on expanding access and elevating care
Aims to build the largest connected healthcare ecosystem in India
Aims to build the largest connected healthcare ecosystem in India
This product will be manufactured at Lupin's Pithampur facility in India
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators
Centre aims to train surgeons and other healthcare professionals from India and Southeast Asia in robotic-assisted surgery
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
The company has entered into a three-year Deferred Prosecution Agreement
Subscribe To Our Newsletter & Stay Updated